References
- 1. The World Health Organization (WHO) updates fact sheet on Top 10 causes of Death, https://communitymedicine4asses.wordpress.com/2017/02/01/who-updates-fact-sheet-on-top-10-causes-of-death-27-january-2017
- 2. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA – Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2014; 383(9913):245-254
- 3. Alves JE, Carneiro A, Xavier J –Reliability of CT perfusion in the evaluation of the ischaemic penumbra. Neuroradiol J 2014; 27(1):91-95
- 4. Fluri F, Schuhmann MK, Kleinschnitz C – Animal models of ischemic stroke and their application in clinical research. Drug Des. Devel. Ther. 2015; 9:3445-3454
- 5. Fuhrer H, Günther A, Zinke J – Optimizing cardiac output to increase cerebral penumbral perfusion in large middle cerebral artery ischemic lesion-OPTIMAL study. Front Neurol. 2017; 8:402
- 6. Rasouli J, Lekhraj R, Ozbalik M, Lalezari P, Casper D – Brain-spleen inflammatory coupling: a literature review. Einstein J Biol Med. 2011; 27(2):74-77
- 7. Courties G, Herisson F, Sager HB, Heidt T, Ye Y, Wei Y, et al – Ischemic stroke activates hematopoietic bone marrow cells. Circ Res. 2015 Jan;116(3):407-17
- 8. Schwartz-Bloom RD, Sah R – gamma-Aminobutyric acid(A) neurotransmission and cerebral ischemia. J Neurochem. 2001; 77(2):353-71
- 9. Mele M, Costa RO, Duarte CB – Alterations in GABAA-Receptor Trafficking and Synaptic Dysfunction in Brain Disorders. Front Cell Neurosci. 2019; 13:77
- 10. Gelderblom M, Leypoldt F, Steinbach K, et al. – Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009; 40(5):1849-1857
- 11. Jin R, Yang G, Li G – Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol. 2010; 87(5):779-789
- 12. Liu ZJ, Chen C, Li FW, et al – Splenic response in ischemic stroke: new insights into stroke pathology. CNS Neurosci Ther. 2015; 21(4):320-326
- 13. Kim E, Yang J, Beltran CD, Cho S – Role of spleen-derived monocytes/macrophages in acute ischemic brain injury. J Cereb Blood Flow Metab. 2014; 34:1411–1419
- 14. Yan FL, Zhang JH – Role of the Sympathetic Nervous System and Spleen in Experimental Stroke-Induced Immunodepression. Med Sci Monit. 2014; 20:2489-2496
- 15. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD – Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab. 2006; 26(5):654-65
- 16. Amantea D, Certo M, Petrelli F, Bagetta G –Neuroprotective Properties of Macrolide Antibiotic in Mouse Model of Middle Cerebral Artery Occlusion: Characterization of the Immunomodulatory Effects and Validation of the Efficacy of Intravenous Administration. Assay Drug Dev Technol. 2016 ;14(5):298-307
- 17. Certo M, Endo Y, Ohta K, Sakurada S, Bagetta G, Amantea D – Activation of RXR/PPAR gamma underlines neuroprotection by bexarotene in ischemic stroke. Pharmacol Res. 2015; 102:298-307
- 18. Seifert HA, Hall AA, Chapman CB, Collier LA, Willing AE, Pennypacker KR – A transient decrease in spleen size following stroke corresponds to splenocyte release into systemic circulation. J Neuroimmune Pharmacol. 2012; 7(4):1017–1024
- 19. Li P, Gan Y, Sun BL, Zhang F, Lu B, Gao Y, et al. Adoptive regulatory T-cell therapy protects against cerebral ischemia. Annals of neurology. 2013;74(3):458–71
- 20. Noble BT, Brennan FH, Popovich PG – The spleen as a neuroimmune interface after spinal cord injury. J. Neuroimmunol. 2018; 321:1–11
- 21. Cesta MF – Normal structure, function, and Histology of the spleen. Toxicol Pathol. 2006; 34:455-465
- 22. Steiniger BS – Human spleen microanatomy: why mice do not suffice. Immunology 2015; 145: 334–346
- 23. Vahidy FS, Parsha KN, Rahbar MH, et al. – Acute splenic responses in patients with ischemic stroke and intracerebral hemorrhage. J Cereb Blood Flow Metab. 2016; 36(6):1012-1021
- 24. Pennypacker KR, Offner H – The role of the spleen in ischemic stroke. J Cereb Blood Flow Metab. 2015; 35(2):186-7
- 25. Okuaki Y, Miyazaki H, Zeniya M, et al. – Splenectomy-reduced hepatic injury induced by ischemia/reperfusion in the rat. Liver. 1996; 16(3):188-194
- 26. Savas MC, Ozguner M, Ozguner IF, Delibas N – Splenectomy attenuates intestinal ischemia-reperfusion-induced acute lung injury. J Pediatr Surg. 2003; 38(10):1465-1470
- 27. Leuschner F, Panizzi P, Chico-Calero I, et al – Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ Res. 2010;107(11):1364-1373
- 28. Hurn PD, Subramanian S, Parker SM, – T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Bood Flow Metab. 2007; 27(11):1798-1805
- 29. Offner H, Subramanian S, Parker SM, et al. – Splenic atrophy in experimental stroke is accompanied by increased regulatory T Cells and circulating macrophages. J Immunol. 2006; 176:6523-6531
- 30. Kriz J – 2006. Inflammation in ischemic brain injury: timing is important. Crit. Rev. Neurobiol. 2006; 18(1-2):145-157
- 31. Ceulemans AG, Zgavc T, Kooijman R, Hachimi-Idrissi S, Sarre S, Michotte Y – The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. J Neuroinflammation. 2010; 1(7):74
- 32. Jickling GC, Liu D, Ander BP, Stamova B, Zhan X, Sharp FR. Targeting neutrophils in ischemic stroke: translational insights from experimental studies. J Cereb Blood Flow Metab. 2015 Jun;35(6):888-901
- 33. Justicia C, Panes J, Sole S, Cervera A, Deulofeu R, Chamorro A, Planas AM. Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab. 2003; 23: 1430–1440
- 34. Rivera S, Ogier C, Jourquin J, Timsit S, Szklarczyk AW, Miller K, Gearing AJ, Kaczmarek L, Khrestchatisky M. Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. Eur J Neurosci. 2002; 15: 19–32
- 35. Montaner J, Alvarez-Sabin J, Molina C, Angles A, Abilleira S, Arenillas J, Gonzalez MA, Monasterio J. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke. 2001; 32: 1759–1766
- 36. Rosell A, Ortega-Aznar A, Alvarez-Sabin, J, et al. – Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 2006; 37:1399-1406
- 37. Yang Y, Rosenberg GA – Matrix metalloproteinases as therapeutic targets for stroke. Brain Res. 2015; 1623:30-38
- 38. Ajmo CT Jr, Collier LA, Leonardo CC et al. Blockade of adrenoreceptors inhibits the splenic response to stroke. Exp Neurol. 2009;218(1):47–55
- 39. Zhang HT, Zhang P, Gao Y, et al. – Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs. Mol. Med. Rep. 2017; 15:57-64
- 40. Woodruff TM, Thundyil J, Tang SC, Sobey CG, Taylor SM, Arumugam TV – Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener. 2011; 6(1):11
- 41. Yilmaz G, Arumugam T V, Stokes K Y, Granger D N. Role of T lymphocytes and interferon-γ in ischemic stroke. Circulation. 2006; 113:2105–2112.
- 42. Hurn P D, Subramanian S, Parker S M, Afentoulis M E, Kaler L J, Vandenbark A A, Offner H. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab. 2007; 27:1798–1805
- 43. Prass K, Meisel C, Höflich C Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation.J Exp Med. 2003 Sep 1;198(5):725-36
- 44. Shi K, Wood K, Shi FD, Wang X, Liu Q. Stroke-induced immunosuppression and poststroke infection.Stroke Vasc Neurol. 2018 Jan 12;3(1):34-41.
- 45. Arumugam T V, Granger D N, Mattson M P. Stroke and T-cells. Neuromolecular Med. 2005; 7:229–242.
- 46. Dotson AL, Zhu W, Libal N, Alkayed NJ, Offner H. Different immunological mechanisms govern protection from experimental stroke in young and older mice with recombinant TCR ligand therapy. Front Cell Neurosci. 2014; 8:284.
- 47. Planas AM, Gómez-Choco M, Urra X, Gorina R, Caballero M, Chamorro Á – Brain-derived antigens in lymphoid tissue of patients with acute stroke. J Immunol. 2012; 188:2156-2163
- 48. Li P, Gan Y, Sun BL, Zhang F, Lu B, Gao Y, et al. Adoptive regulatory T-cell therapy protects against cerebral ischemia. Annals of neurology. 2013;74(3):458–71.
- 49. Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med. 2009;15(2):192–199
- 50. Kleinschnitz C, Kraft P, Dreykluft A, et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood. 2013;121(4):679–691.
- 51. Xia Y, Cai W, Thomson AW, Hu X. Regulatory T Cell Therapy for Ischemic Stroke: how far from Clinical Translation? Transl Stroke Res. 2016;7(5):415-9
- 52. Offner H, Subramanian S, Parker SM, et al. – Splenic atrophy in experimental stroke is accompanied by increased regulatory T Cells and circulating macrophages. J Immunol. 2006; 176:6523-6531
- 53. Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I, Iwaki T, Okada Y, Iida M, Cua D J, Iwakura Y, Yoshimura A. Pivotal role of cerebral interleukin-17-producing γδT cells in the delayed phase of ischemic brain injury. Nat Med. 2009; 15:946–950
- 54. Chen C, Jiang W, Liu Z, et al. – Splenic responses play an important role in remote ischemic preconditioning-mediated neuroprotection against stroke. J Neuroinflammation. 2018;15(1):167
- 55. Rehg JE, Bush D, Ward M – The utility of immunohistochemistry for the identification of hematopoietic and lymphoid cells in normal tissue and interpretation of proliferative and inflammatory lesions of mice and rats. Toxicologic Pathology 2012; 40:345-374
- 56. Chen Y, Bodhankar S, Murphy SJ, Vandenbark AA, Alkayed NJ, Offner H. Intrastriatal B-cell administration limits infarct size after stroke in B-cell deficient mice. Metab Brain Dis. 2012; 27:487–493
- 57. Offner H, Hurn PD. A novel hypothesis: regulatory B lymphocytes shape outcome from experimental stroke. Transl Stroke Res. 2012; 3:324–330
- 58. Schuhmann MK, Langhauser F, Kraft P, Kleinschnitz C – B cells do not have a major pathophysiologic role in acute ischemic stroke in mice. J Neuroinflammation. 2017; 14:112
- 59. Doyle KP, Quach LN, Solé M, et al. – B-lymphocyte-mediated delayed cognitive impairment following stroke. J Neurosci 2015; 35(5):2133-2145
- 60. Bodhankar S, Chen Y, Vandenbark AA, Murphy SJ, Offner H – Treatment of experimental stroke with IL-10-producing B-cells reduces infarct size and peripheral and CNS inflammation in wild-type B-cell-sufficient mice Metab Brain Dis. 2014; 29(1):59-73
- 61. Seifert HA, Leonardo CC, Hall AA et al. –The spleen contributes to stroke induced neurodegeneration through interferon gammasignaling. Metab Brain Dis. 2012; 27(2):131-141.
- 62. Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA – Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16(1):142
- 63. Amantea D. Polarizing the immune system towards neuroprotection in brain ischemia. Neural Regen Res (2016); 11(1):81-82
- 64. Bao Y, Kim E, Bhosle S, Mehta H, Cho S – A role for spleen monocytes in post-ischemic brain inflammation and injury. J Neuroinflammation. 2010; 7:92
- 65. Fumagalli S, Perego C, Pischiutta F, Zanier ER, De Simoni MG – The ischemic environment drives microglia and macrophage function. Front Neurol. 2015; 6: e81
- 66. Kawabori M., Kacimi R., Kauppinen T., Calosing C., Kim J.Y., Hsieh C.L., Nakamura M.C., Yenari M.A. Ttriggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke. J. Neurosci. 2015; 35:3384–3396
- 67. Nakagawa Y, Chiba K. – Role of microglial M1/M2 polarisation in relapse and remission of psychiatric disorders and diseases. Pharmaceuticals (Basel) 2014; 7(12): 1028-1048
- 68. Chiba, T, Umegaki, K –2013. Pivotal Roles of Monocytes/Macrophages in Stroke. Mediators Inflamm. 2013, 759103
- 69. Kanazawa, M., Ninomiya, I., Hatakeyama, M., Takahashi, T., Shimohata, T., 2017. Microglia and monocytes/macrophages polarization reveal novel therapeutic mechanism against stroke. Int J Mol Sci.18(10), E 2135
- 70. Horváth E, Huțanu A, Chiriac L, Dobreanu M, Orãdan A, Nagy EE – Ischemic damage and early inflammatory infiltration are different in the core and penumbra lesions of rat brain after transient focal cerebral ischemia. J Neuroimmunol. 2018; 324:35-42